Chelsea to exercise Christopher Nkunku's £52.8 million release clause. Details here
Twenty-four-year-old Christopher Nkunku was closely associated with Chelsea over the summer. The Blues sought to overhaul numerous areas of their squad, with the forward line being no exception.

Twenty-four-year-old Christopher Nkunku was closely associated with Chelsea over the summer. The Blues sought to overhaul numerous areas of their squad, with the forward line being no exception.
Eventually, Chelsea hired Pierre-Emerick Aubameyang and Raheem Sterling. However, the Blues' troubles in front of goal have not diminished. For the upcoming Crystal Palace Clash over the weekend, talks of Graham Potter dumping Aubameyang in favour of Armando Broja are doing the rounds.
Players like Kai Havertz and Mason Mount haven't yet scored at the club level.
Nkunku's fantastic season at Leipzig made him a target over the summer. In 52 games, the French international scored an astounding 35 goals and provided 20 assists.
Leipzig persisted in forcing Nkunku to sign a contract extension on June 23. Chelsea, however, is interested in the release clause in the contract.
FAQs:
- Did Nkunku undergo secret medicals?
Nkunku is likely to be signed for the fairly modest fee of 60 million euros. Todd Boehly, the part-owner of Chelsea, is set to activate it before a move next summer. Reports claiming that Nkunku has undergone a medical for Chelsea have already emerged. - Where did Nkunku undertake the Chelsea medical?
Preparing for a move in 2023, the medical was reportedly done in Frankfurt one month ago. - What did Christian Falk tweet about the medical?
Bayern Munich specialist Christian Falk confirmed the rumours of a covert physical on Twitter. He reiterated that it was done to have everything in order before the summer 2023 move to Stamford Bridge.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.